New projects on active ageing on the horizon

Both projects submitted by Fraunhofer AICOS to Call 2015 of the Active and Assisted Living Joint Programme (AAL JP) have been approved. The projects are now entering a second phase of negotiation with the funding bodies in each participating country. Throughout the years, the research centre Fraunhofer AICOS (FhP AICOS) has submitted several applications to the AAL JP, since the programme is closely aligned with FhP AICOS’s strategic research agenda. Fraunhofer AICOS has participated in six AAL JP projects, three of them as Coordinator.

These two soon to be active projects target the fields of nutrition and physical activity, which, together, constitute the pillars for successful active ageing. Fraunhofer Portugal AICOS is proud of yet another successful participation in the AAL joint programme. In eight years of this funding programme, FhP AICOS has had six approved projects, three of which as Coordinator, placing us amongst the most successful organisations in designing and participating in AAL JP projects.

The Active and Assisted Living Joint Programme supports applied research on innovative ICT-enhanced services for ageing well, with a time to market of 1 to 3 years. The AAL JP 2013-2020 is driven by Member States and supported by the European Commission, to enhance EU competitiveness and tackle the ageing challenge.

In terms of their impact for FhP AICOS so far, AAL JP projects have provided opportunities for engagement with European and National organisations of different types, e.g. companies, research units and end-user organisations. On the other hand, they have also supported FhP AICOS’s mission of delivering remarkable and easy-to-use technology to the lives of older adults.


“The aim of the AAL JP is to support industry, in particular Small and Medium Enterprises (SME, to bring digital innovative products and services for ageing well to the European market. Another significant added value is the Alignment with the European Innovation Partnership on Active and Healthy Ageing (EIP AHA) could further boost deployment at European scale”.

European Commission